TrueBinding, Inc.: Clinical Trials

4 trials sponsored by TrueBinding, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 terminated, 1 withdrawn. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Active not recruiting 1, Completed 1, Terminated 1, Withdrawn 1
Phase 11Completed 1

Follow TrueBinding, Inc.: new trials by email

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease
TB006, Placebo - Parkinson's Disease (PD)
Phase 2Active not recruitingTrueBinding, Inc.622025-03-202026-04-23
A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease
TB006 - Alzheimer's Disease
Phase 2TerminatedTrueBinding, Inc.1192022-09-152026-05-06
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic Stroke
TB006, Placebo - Acute Ischemic Stroke
Phase 2WithdrawnTrueBinding, Inc.2022-07-262024-01-12
Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease
TB006, Placebo - Alzheimer's Disease
Phase 1 / Phase 2CompletedTrueBinding, Inc.1542021-10-082023-11-18

Conditions studied

Alzheimer Disease (2)  ·  Ischemia (1)  ·  Ischemic Stroke (1)  ·  Parkinson Disease (1)  ·  Stroke (1)

Interventions

TB006 (4)

Countries

United States (3)

Top investigators

Alan K Jacobs, MD (1)